Ladies and gentlemen, thank you for standing-by. Welcome to the Second Quarter 2018 Earnings Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. [Operator Instructions]. As a reminder, this conference is being recorded, Wednesday, July 25th, 2018. I will now turn the conference over to Luis Rojo, Vice President and Chief Financial Officer. Please go ahead, sir.

Good morning and thank you for joining Stepan Company's second quarter 2018 financial review. Before we begin, please note that information in this conference call contains forward-looking statements, which are not historical facts. These statements involve risks and uncertainties that could cause actual results to differ materially, including but not limited to prospects for our foreign operations, global and regional economic conditions and factors detailed in our Securities and Exchange Commission filings. Whether you are joining us online or over the phone, we encourage you to review the investor slide presentation, which we have made available at www.stepan.com, under the Investor Relations section of our website. We make these slides available at approximately the same time as when the earnings release is issued, and we hope that you find information and prospectus helpful. Now with that, I would now like to turn the call over to Quinn Stepan Jr., our Chairman, President and Chief Executive Officer.

Thank you, Luis. And welcome to Stepan Company earnings call. And good morning to you all and thank you for joining us today. Stepan Company had a good second quarter delivering record reported and adjusted net income for both the quarter and the first half of 2018. Second quarter and first half adjusted net income were $32.1 million and $64.1 million respectively, up 4% and 2% from the prior year period. These results were driven by record first half surfactant earnings and a lower 2018 effective tax rate. For the quarter, Surfactant operating income increased 10% over the prior year due to strong North American demand within both the consumer and functional end markets. The Polymer business improved versus first quarter result despite margin and challenge at -- share challenges in our North American polyol business, which we have previously communicated. European polyol volumes matched prior year levels while both global specialty polyols and China delivered earnings growth. Our Specialty Product business results were down, partially due to changing order patterns, but we still anticipate full year income improvement from this segment. Our Board of Directors declared a quarterly cash dividend on Stepan's common stock of 22.5 cents per share payable on September 14, 2018. At this point, I would Luis to walk through a few more details about our second quarter results.

Thank you, Quinn. My comments will generally follow the slide presentation. Let’s start with slide 4 to recap the quarter. As Quinn has stated, adjusted net income for the second quarter 2018 was $32.1 million or $1.38 per diluted share, a 4% increase versus $30.9 million or $1.32 per diluted share in the second quarter of 2017. Because adjusted net income is a non-GAAP measure, we provide full reconciliations to the comparable GAAP measures and this can be found in Appendix 2 of the presentation and Table 2 of the press release. Specifically, adjustments to reported net income this quarter consist of adjustment for deferred compensation income and restructuring expenses. Adjusted net income for the quarter exclude deferred compensation income of $1 million, or $0.04 per diluted share compared to deferred compensation expenses of $2.5 million or $0.11 per diluted share in the same period last year. Naturally all employee compensation expenses are reflected in our normal operating net income. However, we allow employees the opportunity to defer their incentive payouts until some future date, and the future payment change is based on the company's stock price. When the stock price increases, expense is generated as we mark this item to market value. Because the future liability of employee compensation only changes consistently with the change in stock price, we exclude this item from our operational discussion. The current quarter adjusted net income also excluded to $200,000 or $0.01 per diluted share of after-tax business restructuring charges. These charges related to decommissioning costs from the closure of our Canadian plant closure which was announced in 2016. We expect an additional $1 million to $2 million of after-tax restructuring charges in 2018 related to decommissioning costs of both our Canadian and Fieldsboro plant. Slide 5 shows the total company's earnings bridge…

Thank you, Luis. After achieving record first half net income, we remain optimistic about the balance of the year. We believe our surfactant business will continue to build strong start and benefit from our diversification efforts into functional products, new technologies, improved internal efficiencies and expanded sales into our broad customer base globally. Although we expect that margins will continue to challenge our North America Polymer business, we are optimistic about additional volume opportunities during the second half. We believe full year Specialty Product results should improve over 2017. Turning to Slide 10, our leadership position as the largest producer of anionic and amphoteric surfactants for the merchant market in the Western hemisphere was strengthened with the BASF Ecatepec acquisition. Although the acquisition did not contribute to earnings growth for the quarter, it should be slightly accretive for the full year. The acquisition, including sales and cost synergies should contribute between $4 million and $6 million operating income in 2019. Overall, the company's commodity surfactant sales volume grew significantly in the quarter driven by strong performance by our North American consumer product group, partially offset by lower Brazilian volume. We expect that commodity surfactant volumes for the balance of the year should remain strong. Despite previously mentioned headwinds in our rigid polyol business, we remain optimistic about the continued growth of the market due to increased insulation standards, continued energy conservation efforts and the expected growth in construction. We believe that opportunities for our global rigid polyol business in the second half should mostly offset lower margins as we have substantially recaptured previously lost polyol share for the balance of 2018. We still believe that global rigid volumes in the second half of 2018 should meet or even exceed volume shift in the second half of [2017]. Our diversification efforts…

[Operator Instructions]. And our first question comes from the line of David Stratton from Great Lakes Review. Please proceed with your question.

Good morning, guys. I was wondering about -- you mentioned the substantial share recapture in the North American polyol volumes. I was wondering if you could elaborate a little bit about that and just tell us the dynamics that you're seeing currently.

I believe I said we have substantially recaptured our share that we had previously lost for the balance of 2018. So if we look at our share in the marketplace, we have virtually recaptured everything that we had previously lost in North America for the balance of 2018, so.

And is that been a result of competitors changing their strategy or is that a result of you guys really going after that share?

I would say it's -- we were working with our customers and we were able to replace that lost share. And I think it was -- it’s a competitive market, we’re always going to be competitive and we were able to regain that share.

Excellent. And then regarding the Latin American surfactants, I was wondering if you could give us a little bit more color about what you're seeing in that market, especially the puts and takes when you look at you're pushing the Tier 2 and Tier 3 and then some of the softness that you're seeing.

Yes, and let me start with, we've highlighted that our commodity surfactant volume is down in Brazil. We've seen a reformulation that occurred in 2017 and now in 2018 where some surfactant has been replacing formulations of biopolymers. So we believe and we’ve been told that that’s kind of the end of the reformulation activity relative to the polymers in that marketplace. But -- so our volumes on the commodity end of the product portfolio are down. We continue to be excited about the Tier 2 and Tier 3 opportunities and that’s specific in Brazil, and we are selling additional [spheres] to our customer base down there through our Tebras acquisition two years ago. So we continue to be pleased with that. That historically is focused on the laundry and [HI&R] market we are also using that sales force to expand our presence in the Personal Care market. So, from a Tier 2, Tier 3 customer base in Brazil we’ve continued to make progress and are pleased with that. If we take a step back and look at other markets in Latin America, certainly we have a new asset in Mexico that we’re very excited about and we have -- since the acquisition, we have brought new volume in -- both in terms of anionic surfactant and amphoteric surfactants in the market as well received our standard position in the Mexican marketplace and we believer there is going to be future opportunities for volume growth and profit growth in that marketplace.

[Operator Instructions] And our next question comes from the line of Michael Morales with Walthausen & Company. Please proceed with your question.

I was hoping for a little bit more color on the margin pressures that we’re seeing in the North American polymers. We called out the raw material costs. Are there other elements that are contributing to that as well?

I think we highlighted throughout -- last half of 2017 and ‘18 that did see some increased competitive activity in the space. So we’ve seen some movement by some competitors try to capture share and they gave some financial incentives to do that to customers and that's where we’re at today.

Alright. And then the volumes that we recaptured for the share that we lost, was that coming from share gains with new customers, existing customer volumes, can we get some color on that?

In the North American market the rigid polyols was relatively a small customer base. So -- and there's been no significant new entries in that space over a number of years. So we captured share within our existing customer base.

Got it. Thank you. And then maybe shifting gears a little bit, have we heard of any problems on the North American MDI supply at this point?

Yes, so DuPontDow has declared force majeure on their MDI North America. Most of their MDI is used actively to support their European systems business. They do have a presence in the merchant market but not a large presence in the rigid polyol marketplace. So we've reached out and checked with our customers, none of them believed they're going to have any significant impact from the force majeure in the marketplace today.

Got you. So just to clarify our expectation for the higher volumes in North American polymers, that is taking into account the supply headwind coming on the force majeure there?

Yes. And again checking with our customers and specifically with the customer that we’re -- where we've increased that share, they do not anticipate any impact to their business.

Alright. Thank you very much, guys.

[Operator Instructions]. And our next question comes from the line of Curt Siegmeyer from KeyBanc Capital Markets. Please proceed with your question.

Can you just comment maybe how much the new reactor contributed to volumes for the polymer business in the quarter and then your outlook for that business going forward, given your optimism that you commented on around volume opportunities in the rigid polyol business in the second half, just what sort of gives you confidence in those opportunities?

I think the C.A.S.E. volumes in North America were up 6% I believe -- in the first half or the first quarter I'm looking? For the first quarter -- second quarter?

Second quarter.

Second quarter, they were up 6%.

Yes.

So as we look at the year going forward, we would anticipate similar type contributions from that as we approve additional volumes or get approvals from additional volumes at customers that we would anticipate that we would have kind of 6% or so growth for the balance of the year in that end market. So that's really what we're talking about, that level of growth.

Got it, okay. And then on the surfactants business with the -- related to the acquisition in Mexico, you commented on the higher feedstock and supply chain transition costs and the impact that that had in the quarter. Do you anticipate that being a headwind again in the third quarter and just sort of how we should think about that in the second half?

So, we have lost a small amount of money in the first half of the year. We've said that this will be slightly accretive in the second half. So we would be looking at positive contributions in Q3 and growing in Q4 relative to this business side. Not significantly -- overall, not significant impact of 2018 and I mentioned that we would anticipate $4 million to $6 million of operating income in 2019.

Okay, thank you.

And our next question comes from the line of Christopher Hillary with Roubaix Capital. Please proceed with your question.

Hi, good morning. I just wanted to ask you highlight in your slides the low level of net debt and you're obviously completing an acquisition. Can you just discuss what opportunities you see to deploy the balance sheet and are there more or less opportunities than you've been seeing in the recent past to do things that would benefit the business?

Certainly, if you take a step back and look at the chemical industry, the multiples in the chemical industry for acquisitions are relatively high today. So there are a number of -- particularly private companies that are looking to potentially exit a number of their investments that they have made. So relative to the volume of opportunities that are available today in the marketplace and that are being presented to us, the volume I would say is up significantly over the last 12 months. And we’re continuing to look and screen these opportunities, we would like to be more acquisitive, but we want to make sure that we’re buying something that is consistent with our long-term strategy and that we’re paying a fair value for. So we are looking at a number of things and we would like to put some of that money to work. You did see that we increased our share repurchases in the second quarter, again trying to put some of that money to work and we would anticipate some additional share purchase -- repurchases for the balance of the year as well.

Okay. And then maybe just a similar question but a different angle. Are there any projects that you might find compelling in terms of capital expenditures to either improve your productivity or enter new market?

We’ve commented in the past that we continue to look at the non-anionic surfactant space and specifically putting in a significant constellation investment on the Gulf Coast of the United States. So that remains a priority in some month but we’re actively working on organic opportunity to make an investment.

And there are no other questions at this time. I will turn the call back over to you for any closing remarks.

Okay, well. Thank you all for joining us on today's call. We appreciate your interest and you’re your ownership in Stepan Company. We look forward to reporting to you on our third quarter 2018 conference call. Have a great day. Thank you.

Thank you. Ladies and gentlemen, that does conclude the call for today. We thank you for your participation and ask that you please disconnect your lines. Have a great day.